nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—Gemcitabine—hematologic cancer	0.149	0.5	CrCtD
Lamivudine—Cytarabine—hematologic cancer	0.149	0.5	CrCtD
Lamivudine—DCK—hematologic cancer	0.0802	0.475	CbGaD
Lamivudine—ABCC3—hematologic cancer	0.0372	0.22	CbGaD
Lamivudine—SLC22A1—hematologic cancer	0.0259	0.153	CbGaD
Lamivudine—Gemcitabine—Cytarabine—hematologic cancer	0.0255	0.133	CrCrCtD
Lamivudine—CMPK1—Gemcitabine—hematologic cancer	0.0228	0.105	CbGbCtD
Lamivudine—Zalcitabine—Cytarabine—hematologic cancer	0.022	0.115	CrCrCtD
Lamivudine—Zalcitabine—Gemcitabine—hematologic cancer	0.022	0.115	CrCrCtD
Lamivudine—DCK—Nelarabine—hematologic cancer	0.0202	0.0932	CbGbCtD
Lamivudine—DCK—Clofarabine—hematologic cancer	0.0185	0.0853	CbGbCtD
Lamivudine—ABCG2—hematologic cancer	0.0181	0.107	CbGaD
Lamivudine—Decitabine—Pentostatin—hematologic cancer	0.0155	0.0808	CrCrCtD
Lamivudine—Cytarabine—Clofarabine—hematologic cancer	0.0153	0.0796	CrCrCtD
Lamivudine—Cytarabine—Nelarabine—hematologic cancer	0.0144	0.0749	CrCrCtD
Lamivudine—DCK—Fludarabine—hematologic cancer	0.014	0.0646	CbGbCtD
Lamivudine—Decitabine—Clofarabine—hematologic cancer	0.0138	0.072	CrCrCtD
Lamivudine—Decitabine—Nelarabine—hematologic cancer	0.013	0.0677	CrCrCtD
Lamivudine—Cytarabine—Fludarabine—hematologic cancer	0.0112	0.0585	CrCrCtD
Lamivudine—Cytarabine—Gemcitabine—hematologic cancer	0.0106	0.0552	CrCrCtD
Lamivudine—Decitabine—Gemcitabine—hematologic cancer	0.00958	0.0499	CrCrCtD
Lamivudine—Decitabine—Cytarabine—hematologic cancer	0.00958	0.0499	CrCrCtD
Lamivudine—DCK—Cytarabine—hematologic cancer	0.00956	0.0441	CbGbCtD
Lamivudine—Decitabine—Cladribine—hematologic cancer	0.00934	0.0487	CrCrCtD
Lamivudine—DCK—Cladribine—hematologic cancer	0.00903	0.0416	CbGbCtD
Lamivudine—ABCC4—Tioguanine—hematologic cancer	0.00801	0.0369	CbGbCtD
Lamivudine—ABCB1—hematologic cancer	0.00752	0.0445	CbGaD
Lamivudine—SLC22A3—Melphalan—hematologic cancer	0.00747	0.0345	CbGbCtD
Lamivudine—DCK—Gemcitabine—hematologic cancer	0.00582	0.0268	CbGbCtD
Lamivudine—ABCC1—Idarubicin—hematologic cancer	0.00488	0.0225	CbGbCtD
Lamivudine—ABCG2—Clofarabine—hematologic cancer	0.00394	0.0182	CbGbCtD
Lamivudine—ABCC1—Daunorubicin—hematologic cancer	0.00345	0.0159	CbGbCtD
Lamivudine—ABCC4—Mercaptopurine—hematologic cancer	0.00333	0.0153	CbGbCtD
Lamivudine—SLC22A2—Daunorubicin—hematologic cancer	0.00313	0.0144	CbGbCtD
Lamivudine—SLC22A2—Cytarabine—hematologic cancer	0.00276	0.0127	CbGbCtD
Lamivudine—SLC22A2—Cladribine—hematologic cancer	0.00261	0.012	CbGbCtD
Lamivudine—ABCC2—Daunorubicin—hematologic cancer	0.00256	0.0118	CbGbCtD
Lamivudine—SLC22A3—Irinotecan—hematologic cancer	0.00253	0.0117	CbGbCtD
Lamivudine—SLC22A1—Cytarabine—hematologic cancer	0.0024	0.0111	CbGbCtD
Lamivudine—SLC22A2—Imatinib—hematologic cancer	0.0024	0.0111	CbGbCtD
Lamivudine—ABCC3—Vincristine—hematologic cancer	0.00235	0.0108	CbGbCtD
Lamivudine—ABCG2—Daunorubicin—hematologic cancer	0.00231	0.0107	CbGbCtD
Lamivudine—SLC22A1—Cladribine—hematologic cancer	0.00226	0.0104	CbGbCtD
Lamivudine—SLC22A3—Vincristine—hematologic cancer	0.00221	0.0102	CbGbCtD
Lamivudine—ABCC3—Cisplatin—hematologic cancer	0.00219	0.0101	CbGbCtD
Lamivudine—ABCC3—Etoposide—hematologic cancer	0.00215	0.00993	CbGbCtD
Lamivudine—ABCC1—Mitoxantrone—hematologic cancer	0.0021	0.00967	CbGbCtD
Lamivudine—SLC22A1—Imatinib—hematologic cancer	0.00208	0.0096	CbGbCtD
Lamivudine—ABCG2—Teniposide—hematologic cancer	0.00201	0.00925	CbGbCtD
Lamivudine—ABCG2—Cladribine—hematologic cancer	0.00192	0.00887	CbGbCtD
Lamivudine—ABCG2—Imatinib—hematologic cancer	0.00177	0.00816	CbGbCtD
Lamivudine—ABCC1—Epirubicin—hematologic cancer	0.0017	0.00783	CbGbCtD
Lamivudine—ABCC1—Irinotecan—hematologic cancer	0.00165	0.00761	CbGbCtD
Lamivudine—ABCG2—Nilotinib—hematologic cancer	0.00161	0.00741	CbGbCtD
Lamivudine—ABCC3—Doxorubicin—hematologic cancer	0.00147	0.00678	CbGbCtD
Lamivudine—ABCC1—Vinblastine—hematologic cancer	0.00147	0.00677	CbGbCtD
Lamivudine—ABCC1—Vincristine—hematologic cancer	0.00144	0.00666	CbGbCtD
Lamivudine—ABCC3—Methotrexate—hematologic cancer	0.00142	0.00656	CbGbCtD
Lamivudine—ABCG2—Dasatinib—hematologic cancer	0.00142	0.00655	CbGbCtD
Lamivudine—ABCB1—Lenalidomide—hematologic cancer	0.00142	0.00655	CbGbCtD
Lamivudine—ABCG2—Mitoxantrone—hematologic cancer	0.0014	0.00647	CbGbCtD
Lamivudine—SLC22A2—Vinblastine—hematologic cancer	0.00133	0.00614	CbGbCtD
Lamivudine—ABCC1—Etoposide—hematologic cancer	0.00132	0.0061	CbGbCtD
Lamivudine—ABCC2—Irinotecan—hematologic cancer	0.00122	0.00564	CbGbCtD
Lamivudine—SLC22A2—Cisplatin—hematologic cancer	0.00122	0.00563	CbGbCtD
Lamivudine—ABCG2—Irinotecan—hematologic cancer	0.00111	0.0051	CbGbCtD
Lamivudine—ABCC4—Methotrexate—hematologic cancer	0.00109	0.00501	CbGbCtD
Lamivudine—ABCC2—Vinblastine—hematologic cancer	0.00109	0.00501	CbGbCtD
Lamivudine—ABCC2—Vincristine—hematologic cancer	0.00107	0.00493	CbGbCtD
Lamivudine—PGK1—hematopoietic system—hematologic cancer	0.00102	0.0469	CbGeAlD
Lamivudine—ABCC2—Cisplatin—hematologic cancer	0.000997	0.00459	CbGbCtD
Lamivudine—ABCC2—Etoposide—hematologic cancer	0.000979	0.00451	CbGbCtD
Lamivudine—ABCG2—Vincristine—hematologic cancer	0.000966	0.00445	CbGbCtD
Lamivudine—NME1-NME2—hematopoietic system—hematologic cancer	0.000927	0.0427	CbGeAlD
Lamivudine—ABCC1—Doxorubicin—hematologic cancer	0.000902	0.00416	CbGbCtD
Lamivudine—ABCG2—Cisplatin—hematologic cancer	0.000901	0.00415	CbGbCtD
Lamivudine—PCYT2—gonad—hematologic cancer	0.000901	0.0415	CbGeAlD
Lamivudine—ABCG2—Etoposide—hematologic cancer	0.000885	0.00408	CbGbCtD
Lamivudine—ABCC1—Methotrexate—hematologic cancer	0.000874	0.00403	CbGbCtD
Lamivudine—NT5C—hematopoietic system—hematologic cancer	0.000859	0.0396	CbGeAlD
Lamivudine—ABCB1—Daunorubicin—hematologic cancer	0.000833	0.00384	CbGbCtD
Lamivudine—ABCB1—Alitretinoin—hematologic cancer	0.000816	0.00376	CbGbCtD
Lamivudine—PCYT1A—hematopoietic system—hematologic cancer	0.000807	0.0372	CbGeAlD
Lamivudine—ABCC2—Dexamethasone—hematologic cancer	0.000805	0.00371	CbGbCtD
Lamivudine—PGK1—gonad—hematologic cancer	0.000774	0.0357	CbGeAlD
Lamivudine—ABCG2—Dexamethasone—hematologic cancer	0.000728	0.00336	CbGbCtD
Lamivudine—PGK1—blood—hematologic cancer	0.000674	0.0311	CbGeAlD
Lamivudine—ABCC2—Doxorubicin—hematologic cancer	0.000668	0.00308	CbGbCtD
Lamivudine—PCYT2—testis—hematologic cancer	0.000649	0.0299	CbGeAlD
Lamivudine—ABCC2—Methotrexate—hematologic cancer	0.000647	0.00298	CbGbCtD
Lamivudine—ABCB1—Imatinib—hematologic cancer	0.000638	0.00294	CbGbCtD
Lamivudine—PCYT1A—gonad—hematologic cancer	0.000613	0.0283	CbGeAlD
Lamivudine—ABCG2—Doxorubicin—hematologic cancer	0.000604	0.00278	CbGbCtD
Lamivudine—ABCG2—Methotrexate—hematologic cancer	0.000585	0.0027	CbGbCtD
Lamivudine—ABCB1—Nilotinib—hematologic cancer	0.00058	0.00267	CbGbCtD
Lamivudine—ABCB1—Vinorelbine—hematologic cancer	0.000575	0.00265	CbGbCtD
Lamivudine—NT5C—blood—hematologic cancer	0.000569	0.0263	CbGeAlD
Lamivudine—PGK1—testis—hematologic cancer	0.000558	0.0257	CbGeAlD
Lamivudine—Emtricitabine—DCK—hematologic cancer	0.000542	0.299	CrCbGaD
Lamivudine—NME1—hematopoietic system—hematologic cancer	0.000539	0.0249	CbGeAlD
Lamivudine—CMPK1—hematopoietic system—hematologic cancer	0.00052	0.024	CbGeAlD
Lamivudine—ABCB1—Dasatinib—hematologic cancer	0.000512	0.00236	CbGbCtD
Lamivudine—NME2—hematopoietic system—hematologic cancer	0.000508	0.0234	CbGeAlD
Lamivudine—ABCB1—Mitoxantrone—hematologic cancer	0.000506	0.00233	CbGbCtD
Lamivudine—NT5C—lung—hematologic cancer	0.000499	0.023	CbGeAlD
Lamivudine—SLC22A6—Methotrexate—hematologic cancer	0.000473	0.00218	CbGbCtD
Lamivudine—NT5C—testis—hematologic cancer	0.000471	0.0217	CbGeAlD
Lamivudine—PCYT1A—lung—hematologic cancer	0.000468	0.0216	CbGeAlD
Lamivudine—ABCB1—Betamethasone—hematologic cancer	0.000451	0.00208	CbGbCtD
Lamivudine—ABCB1—Gemcitabine—hematologic cancer	0.000447	0.00206	CbGbCtD
Lamivudine—ABCB1—Prednisolone—hematologic cancer	0.000445	0.00205	CbGbCtD
Lamivudine—PCYT1A—testis—hematologic cancer	0.000442	0.0204	CbGeAlD
Lamivudine—ABCB1—Prednisone—hematologic cancer	0.00042	0.00194	CbGbCtD
Lamivudine—ABCB1—Irinotecan—hematologic cancer	0.000399	0.00184	CbGbCtD
Lamivudine—CMPK1—gonad—hematologic cancer	0.000395	0.0182	CbGeAlD
Lamivudine—NME1-NME2—lymph node—hematologic cancer	0.000368	0.017	CbGeAlD
Lamivudine—ABCB1—Vinblastine—hematologic cancer	0.000354	0.00163	CbGbCtD
Lamivudine—ABCB1—Vincristine—hematologic cancer	0.000348	0.00161	CbGbCtD
Lamivudine—NME1—bone marrow—hematologic cancer	0.000346	0.0159	CbGeAlD
Lamivudine—CMPK1—blood—hematologic cancer	0.000344	0.0159	CbGeAlD
Lamivudine—NT5C—lymph node—hematologic cancer	0.000341	0.0157	CbGeAlD
Lamivudine—NME2—blood—hematologic cancer	0.000337	0.0155	CbGeAlD
Lamivudine—CMPK1—bone marrow—hematologic cancer	0.000333	0.0154	CbGeAlD
Lamivudine—ABCB1—Cisplatin—hematologic cancer	0.000325	0.0015	CbGbCtD
Lamivudine—ABCB1—Etoposide—hematologic cancer	0.000319	0.00147	CbGbCtD
Lamivudine—NME1—lung—hematologic cancer	0.000313	0.0144	CbGeAlD
Lamivudine—CMPK1—lung—hematologic cancer	0.000302	0.0139	CbGeAlD
Lamivudine—NME1—testis—hematologic cancer	0.000296	0.0136	CbGeAlD
Lamivudine—NME2—lung—hematologic cancer	0.000295	0.0136	CbGeAlD
Lamivudine—CMPK1—testis—hematologic cancer	0.000285	0.0131	CbGeAlD
Lamivudine—NME2—testis—hematologic cancer	0.000278	0.0128	CbGeAlD
Lamivudine—ABCB1—Dexamethasone—hematologic cancer	0.000262	0.00121	CbGbCtD
Lamivudine—DCK—hematopoietic system—hematologic cancer	0.000259	0.0119	CbGeAlD
Lamivudine—Decitabine—DNMT3A—hematologic cancer	0.000249	0.138	CrCbGaD
Lamivudine—ABCC3—hematopoietic system—hematologic cancer	0.000248	0.0114	CbGeAlD
Lamivudine—ABCB1—Doxorubicin—hematologic cancer	0.000218	0.001	CbGbCtD
Lamivudine—NME1—lymph node—hematologic cancer	0.000214	0.00988	CbGeAlD
Lamivudine—SLC22A3—hematopoietic system—hematologic cancer	0.000211	0.00972	CbGeAlD
Lamivudine—ABCB1—Methotrexate—hematologic cancer	0.000211	0.000972	CbGbCtD
Lamivudine—CMPK1—lymph node—hematologic cancer	0.000206	0.00952	CbGeAlD
Lamivudine—ABCC4—hematopoietic system—hematologic cancer	0.000205	0.00943	CbGeAlD
Lamivudine—NME2—lymph node—hematologic cancer	0.000202	0.0093	CbGeAlD
Lamivudine—DCK—gonad—hematologic cancer	0.000197	0.00907	CbGeAlD
Lamivudine—NME1—Ponatinib—Nilotinib—hematologic cancer	0.000196	0.217	CbGdCrCtD
Lamivudine—Decitabine—DCK—hematologic cancer	0.000196	0.108	CrCbGaD
Lamivudine—Gemcitabine—CDA—hematologic cancer	0.000191	0.105	CrCbGaD
Lamivudine—DCK—blood—hematologic cancer	0.000171	0.0079	CbGeAlD
Lamivudine—Zalcitabine—DCK—hematologic cancer	0.00017	0.0941	CrCbGaD
Lamivudine—Gemcitabine—DCK—hematologic cancer	0.000168	0.0925	CrCbGaD
Lamivudine—DCK—bone marrow—hematologic cancer	0.000166	0.00765	CbGeAlD
Lamivudine—ABCC3—blood—hematologic cancer	0.000164	0.00757	CbGeAlD
Lamivudine—SLC22A3—gonad—hematologic cancer	0.00016	0.00739	CbGeAlD
Lamivudine—DCK—lung—hematologic cancer	0.00015	0.00693	CbGeAlD
Lamivudine—NME1—Ponatinib—Imatinib—hematologic cancer	0.000149	0.164	CbGdCrCtD
Lamivudine—SLC22A1—blood—hematologic cancer	0.000146	0.00674	CbGeAlD
Lamivudine—ABCC3—lung—hematologic cancer	0.000144	0.00663	CbGeAlD
Lamivudine—DCK—testis—hematologic cancer	0.000142	0.00654	CbGeAlD
Lamivudine—ABCC3—testis—hematologic cancer	0.000136	0.00626	CbGeAlD
Lamivudine—ABCC4—blood—hematologic cancer	0.000135	0.00625	CbGeAlD
Lamivudine—ABCC2—blood—hematologic cancer	0.000131	0.00605	CbGeAlD
Lamivudine—ABCC4—bone marrow—hematologic cancer	0.000131	0.00604	CbGeAlD
Lamivudine—Cytarabine—CDA—hematologic cancer	0.00013	0.0717	CrCbGaD
Lamivudine—SLC22A3—lung—hematologic cancer	0.000123	0.00565	CbGeAlD
Lamivudine—ABCC4—lung—hematologic cancer	0.000119	0.00548	CbGeAlD
Lamivudine—SLC22A3—testis—hematologic cancer	0.000116	0.00533	CbGeAlD
Lamivudine—ABCC1—blood—hematologic cancer	0.000116	0.00533	CbGeAlD
Lamivudine—Cytarabine—DCK—hematologic cancer	0.000114	0.0631	CrCbGaD
Lamivudine—ABCC4—testis—hematologic cancer	0.000112	0.00517	CbGeAlD
Lamivudine—ABCC2—testis—hematologic cancer	0.000108	0.005	CbGeAlD
Lamivudine—DCK—lymph node—hematologic cancer	0.000103	0.00474	CbGeAlD
Lamivudine—ABCC1—lung—hematologic cancer	0.000101	0.00467	CbGeAlD
Lamivudine—ABCC3—lymph node—hematologic cancer	9.84e-05	0.00454	CbGeAlD
Lamivudine—DCK—Topotecan—Irinotecan—hematologic cancer	9.6e-05	0.106	CbGdCrCtD
Lamivudine—ABCG2—blood—hematologic cancer	9.56e-05	0.00441	CbGeAlD
Lamivudine—ABCC1—testis—hematologic cancer	9.56e-05	0.00441	CbGeAlD
Lamivudine—ABCG2—bone marrow—hematologic cancer	9.25e-05	0.00427	CbGeAlD
Lamivudine—ABCG2—lung—hematologic cancer	8.38e-05	0.00387	CbGeAlD
Lamivudine—SLC22A3—lymph node—hematologic cancer	8.38e-05	0.00386	CbGeAlD
Lamivudine—ABCC4—lymph node—hematologic cancer	8.12e-05	0.00375	CbGeAlD
Lamivudine—ABCG2—testis—hematologic cancer	7.91e-05	0.00365	CbGeAlD
Lamivudine—ABCC2—lymph node—hematologic cancer	7.86e-05	0.00363	CbGeAlD
Lamivudine—ABCB1—hematopoietic system—hematologic cancer	7.12e-05	0.00328	CbGeAlD
Lamivudine—ABCC1—lymph node—hematologic cancer	6.93e-05	0.00319	CbGeAlD
Lamivudine—DCK—Doxorubicin—Daunorubicin—hematologic cancer	6.49e-05	0.0715	CbGdCrCtD
Lamivudine—DCK—Epirubicin—Daunorubicin—hematologic cancer	6.49e-05	0.0715	CbGdCrCtD
Lamivudine—ABCG2—lymph node—hematologic cancer	5.73e-05	0.00264	CbGeAlD
Lamivudine—DCK—Menadione—Thalidomide—hematologic cancer	5.51e-05	0.0608	CbGdCrCtD
Lamivudine—ABCB1—gonad—hematologic cancer	5.41e-05	0.0025	CbGeAlD
Lamivudine—DCK—Epirubicin—Idarubicin—hematologic cancer	4.91e-05	0.0542	CbGdCrCtD
Lamivudine—DCK—Doxorubicin—Idarubicin—hematologic cancer	4.91e-05	0.0542	CbGdCrCtD
Lamivudine—ABCB1—blood—hematologic cancer	4.72e-05	0.00217	CbGeAlD
Lamivudine—ABCB1—bone marrow—hematologic cancer	4.56e-05	0.0021	CbGeAlD
Lamivudine—ABCB1—lung—hematologic cancer	4.13e-05	0.00191	CbGeAlD
Lamivudine—ABCB1—testis—hematologic cancer	3.9e-05	0.0018	CbGeAlD
Lamivudine—Cytarabine—SLC22A1—hematologic cancer	3.69e-05	0.0204	CrCbGaD
Lamivudine—ABCB1—lymph node—hematologic cancer	2.83e-05	0.0013	CbGeAlD
Lamivudine—DCK—Doxorubicin—Epirubicin—hematologic cancer	2.26e-05	0.0249	CbGdCrCtD
Lamivudine—DCK—Epirubicin—Doxorubicin—hematologic cancer	2.09e-05	0.023	CbGdCrCtD
Lamivudine—Gemcitabine—ABCB1—hematologic cancer	1.57e-05	0.00868	CrCbGaD
Lamivudine—NME1—Fluticasone Propionate—Betamethasone—hematologic cancer	1.5e-05	0.0166	CbGdCrCtD
Lamivudine—NME1—Fluticasone Propionate—Dexamethasone—hematologic cancer	1.5e-05	0.0166	CbGdCrCtD
Lamivudine—NME1—Fluticasone Propionate—Triamcinolone—hematologic cancer	1.47e-05	0.0162	CbGdCrCtD
Lamivudine—DCK—Desoximetasone—Dexamethasone—hematologic cancer	9.97e-06	0.011	CbGdCrCtD
Lamivudine—DCK—Desoximetasone—Betamethasone—hematologic cancer	9.97e-06	0.011	CbGdCrCtD
Lamivudine—DCK—Desoximetasone—Triamcinolone—hematologic cancer	9.74e-06	0.0107	CbGdCrCtD
Lamivudine—DCK—Diflorasone—Betamethasone—hematologic cancer	9.67e-06	0.0107	CbGdCrCtD
Lamivudine—DCK—Diflorasone—Dexamethasone—hematologic cancer	9.67e-06	0.0107	CbGdCrCtD
Lamivudine—DCK—Diflorasone—Triamcinolone—hematologic cancer	9.45e-06	0.0104	CbGdCrCtD
Lamivudine—DCK—Desoximetasone—Prednisone—hematologic cancer	9.24e-06	0.0102	CbGdCrCtD
Lamivudine—DCK—Desoximetasone—Prednisolone—hematologic cancer	9.02e-06	0.00994	CbGdCrCtD
Lamivudine—DCK—Diflorasone—Prednisone—hematologic cancer	8.97e-06	0.00989	CbGdCrCtD
Lamivudine—DCK—Diflorasone—Prednisolone—hematologic cancer	8.76e-06	0.00965	CbGdCrCtD
Lamivudine—Vomiting—Cisplatin—hematologic cancer	5.03e-06	7.91e-05	CcSEcCtD
Lamivudine—Hyperhidrosis—Prednisone—hematologic cancer	5.02e-06	7.9e-05	CcSEcCtD
Lamivudine—Erythema multiforme—Doxorubicin—hematologic cancer	5e-06	7.87e-05	CcSEcCtD
Lamivudine—Rash—Cisplatin—hematologic cancer	4.99e-06	7.85e-05	CcSEcCtD
Lamivudine—Dermatitis—Cisplatin—hematologic cancer	4.98e-06	7.84e-05	CcSEcCtD
Lamivudine—Erythema—Epirubicin—hematologic cancer	4.98e-06	7.83e-05	CcSEcCtD
Lamivudine—Malnutrition—Epirubicin—hematologic cancer	4.98e-06	7.83e-05	CcSEcCtD
Lamivudine—Diarrhoea—Etoposide—hematologic cancer	4.96e-06	7.8e-05	CcSEcCtD
Lamivudine—Anorexia—Prednisone—hematologic cancer	4.95e-06	7.79e-05	CcSEcCtD
Lamivudine—Ill-defined disorder—Methotrexate—hematologic cancer	4.93e-06	7.77e-05	CcSEcCtD
Lamivudine—Anaemia—Methotrexate—hematologic cancer	4.92e-06	7.74e-05	CcSEcCtD
Lamivudine—Feeling abnormal—Betamethasone—hematologic cancer	4.91e-06	7.73e-05	CcSEcCtD
Lamivudine—Feeling abnormal—Dexamethasone—hematologic cancer	4.91e-06	7.73e-05	CcSEcCtD
Lamivudine—Flatulence—Epirubicin—hematologic cancer	4.9e-06	7.72e-05	CcSEcCtD
Lamivudine—Tension—Epirubicin—hematologic cancer	4.88e-06	7.69e-05	CcSEcCtD
Lamivudine—Gastrointestinal pain—Betamethasone—hematologic cancer	4.88e-06	7.67e-05	CcSEcCtD
Lamivudine—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.88e-06	7.67e-05	CcSEcCtD
Lamivudine—Dysgeusia—Epirubicin—hematologic cancer	4.87e-06	7.67e-05	CcSEcCtD
Lamivudine—Hypersensitivity—Triamcinolone—hematologic cancer	4.84e-06	7.62e-05	CcSEcCtD
Lamivudine—Nervousness—Epirubicin—hematologic cancer	4.83e-06	7.61e-05	CcSEcCtD
Lamivudine—Back pain—Epirubicin—hematologic cancer	4.81e-06	7.58e-05	CcSEcCtD
Lamivudine—Malaise—Methotrexate—hematologic cancer	4.8e-06	7.55e-05	CcSEcCtD
Lamivudine—Dizziness—Etoposide—hematologic cancer	4.79e-06	7.54e-05	CcSEcCtD
Lamivudine—Muscle spasms—Epirubicin—hematologic cancer	4.78e-06	7.53e-05	CcSEcCtD
Lamivudine—Immune system disorder—Doxorubicin—hematologic cancer	4.78e-06	7.52e-05	CcSEcCtD
Lamivudine—Vertigo—Methotrexate—hematologic cancer	4.78e-06	7.52e-05	CcSEcCtD
Lamivudine—Mediastinal disorder—Doxorubicin—hematologic cancer	4.77e-06	7.5e-05	CcSEcCtD
Lamivudine—Leukopenia—Methotrexate—hematologic cancer	4.76e-06	7.49e-05	CcSEcCtD
Lamivudine—Chills—Doxorubicin—hematologic cancer	4.75e-06	7.47e-05	CcSEcCtD
Lamivudine—Urticaria—Dexamethasone—hematologic cancer	4.74e-06	7.46e-05	CcSEcCtD
Lamivudine—Urticaria—Betamethasone—hematologic cancer	4.74e-06	7.46e-05	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.73e-06	7.45e-05	CcSEcCtD
Lamivudine—Dizziness—Prednisolone—hematologic cancer	4.73e-06	7.44e-05	CcSEcCtD
Lamivudine—Asthenia—Triamcinolone—hematologic cancer	4.72e-06	7.42e-05	CcSEcCtD
Lamivudine—Body temperature increased—Betamethasone—hematologic cancer	4.71e-06	7.42e-05	CcSEcCtD
Lamivudine—Abdominal pain—Dexamethasone—hematologic cancer	4.71e-06	7.42e-05	CcSEcCtD
Lamivudine—Abdominal pain—Betamethasone—hematologic cancer	4.71e-06	7.42e-05	CcSEcCtD
Lamivudine—Body temperature increased—Dexamethasone—hematologic cancer	4.71e-06	7.42e-05	CcSEcCtD
Lamivudine—Nausea—Cisplatin—hematologic cancer	4.7e-06	7.39e-05	CcSEcCtD
Lamivudine—Insomnia—Prednisone—hematologic cancer	4.7e-06	7.39e-05	CcSEcCtD
Lamivudine—Alopecia—Doxorubicin—hematologic cancer	4.67e-06	7.36e-05	CcSEcCtD
Lamivudine—Paraesthesia—Prednisone—hematologic cancer	4.66e-06	7.34e-05	CcSEcCtD
Lamivudine—Pruritus—Triamcinolone—hematologic cancer	4.65e-06	7.32e-05	CcSEcCtD
Lamivudine—Cough—Methotrexate—hematologic cancer	4.64e-06	7.3e-05	CcSEcCtD
Lamivudine—Ill-defined disorder—Epirubicin—hematologic cancer	4.62e-06	7.27e-05	CcSEcCtD
Lamivudine—Convulsion—Methotrexate—hematologic cancer	4.61e-06	7.25e-05	CcSEcCtD
Lamivudine—Vomiting—Etoposide—hematologic cancer	4.61e-06	7.25e-05	CcSEcCtD
Lamivudine—Erythema—Doxorubicin—hematologic cancer	4.6e-06	7.25e-05	CcSEcCtD
Lamivudine—Malnutrition—Doxorubicin—hematologic cancer	4.6e-06	7.25e-05	CcSEcCtD
Lamivudine—Anaemia—Epirubicin—hematologic cancer	4.6e-06	7.24e-05	CcSEcCtD
Lamivudine—Dyspepsia—Prednisone—hematologic cancer	4.57e-06	7.19e-05	CcSEcCtD
Lamivudine—Rash—Etoposide—hematologic cancer	4.57e-06	7.19e-05	CcSEcCtD
Lamivudine—Dermatitis—Etoposide—hematologic cancer	4.56e-06	7.18e-05	CcSEcCtD
Lamivudine—Headache—Etoposide—hematologic cancer	4.54e-06	7.14e-05	CcSEcCtD
Lamivudine—Flatulence—Doxorubicin—hematologic cancer	4.54e-06	7.14e-05	CcSEcCtD
Lamivudine—Myalgia—Methotrexate—hematologic cancer	4.53e-06	7.13e-05	CcSEcCtD
Lamivudine—Arthralgia—Methotrexate—hematologic cancer	4.53e-06	7.13e-05	CcSEcCtD
Lamivudine—Chest pain—Methotrexate—hematologic cancer	4.53e-06	7.13e-05	CcSEcCtD
Lamivudine—Tension—Doxorubicin—hematologic cancer	4.52e-06	7.11e-05	CcSEcCtD
Lamivudine—Decreased appetite—Prednisone—hematologic cancer	4.51e-06	7.11e-05	CcSEcCtD
Lamivudine—Dysgeusia—Doxorubicin—hematologic cancer	4.51e-06	7.1e-05	CcSEcCtD
Lamivudine—Rash—Prednisolone—hematologic cancer	4.51e-06	7.09e-05	CcSEcCtD
Lamivudine—Dermatitis—Prednisolone—hematologic cancer	4.5e-06	7.09e-05	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.5e-06	7.08e-05	CcSEcCtD
Lamivudine—Malaise—Epirubicin—hematologic cancer	4.49e-06	7.06e-05	CcSEcCtD
Lamivudine—Fatigue—Prednisone—hematologic cancer	4.48e-06	7.05e-05	CcSEcCtD
Lamivudine—Headache—Prednisolone—hematologic cancer	4.48e-06	7.05e-05	CcSEcCtD
Lamivudine—Discomfort—Methotrexate—hematologic cancer	4.47e-06	7.04e-05	CcSEcCtD
Lamivudine—Nervousness—Doxorubicin—hematologic cancer	4.47e-06	7.04e-05	CcSEcCtD
Lamivudine—Vertigo—Epirubicin—hematologic cancer	4.47e-06	7.04e-05	CcSEcCtD
Lamivudine—Syncope—Epirubicin—hematologic cancer	4.46e-06	7.02e-05	CcSEcCtD
Lamivudine—Leukopenia—Epirubicin—hematologic cancer	4.45e-06	7.01e-05	CcSEcCtD
Lamivudine—Back pain—Doxorubicin—hematologic cancer	4.45e-06	7.01e-05	CcSEcCtD
Lamivudine—Constipation—Prednisone—hematologic cancer	4.44e-06	6.99e-05	CcSEcCtD
Lamivudine—Muscle spasms—Doxorubicin—hematologic cancer	4.43e-06	6.97e-05	CcSEcCtD
Lamivudine—Confusional state—Methotrexate—hematologic cancer	4.38e-06	6.89e-05	CcSEcCtD
Lamivudine—Loss of consciousness—Epirubicin—hematologic cancer	4.37e-06	6.88e-05	CcSEcCtD
Lamivudine—Dizziness—Triamcinolone—hematologic cancer	4.35e-06	6.84e-05	CcSEcCtD
Lamivudine—Cough—Epirubicin—hematologic cancer	4.34e-06	6.84e-05	CcSEcCtD
Lamivudine—Anaphylactic shock—Methotrexate—hematologic cancer	4.34e-06	6.83e-05	CcSEcCtD
Lamivudine—Convulsion—Epirubicin—hematologic cancer	4.31e-06	6.79e-05	CcSEcCtD
Lamivudine—Infection—Methotrexate—hematologic cancer	4.31e-06	6.79e-05	CcSEcCtD
Lamivudine—Nausea—Etoposide—hematologic cancer	4.3e-06	6.77e-05	CcSEcCtD
Lamivudine—Feeling abnormal—Prednisone—hematologic cancer	4.28e-06	6.74e-05	CcSEcCtD
Lamivudine—Asthenia—Dexamethasone—hematologic cancer	4.28e-06	6.73e-05	CcSEcCtD
Lamivudine—Asthenia—Betamethasone—hematologic cancer	4.28e-06	6.73e-05	CcSEcCtD
Lamivudine—Ill-defined disorder—Doxorubicin—hematologic cancer	4.27e-06	6.72e-05	CcSEcCtD
Lamivudine—Nervous system disorder—Methotrexate—hematologic cancer	4.26e-06	6.7e-05	CcSEcCtD
Lamivudine—Anaemia—Doxorubicin—hematologic cancer	4.26e-06	6.7e-05	CcSEcCtD
Lamivudine—Thrombocytopenia—Methotrexate—hematologic cancer	4.25e-06	6.69e-05	CcSEcCtD
Lamivudine—Gastrointestinal pain—Prednisone—hematologic cancer	4.25e-06	6.68e-05	CcSEcCtD
Lamivudine—Nausea—Prednisolone—hematologic cancer	4.25e-06	6.68e-05	CcSEcCtD
Lamivudine—Arthralgia—Epirubicin—hematologic cancer	4.24e-06	6.67e-05	CcSEcCtD
Lamivudine—Chest pain—Epirubicin—hematologic cancer	4.24e-06	6.67e-05	CcSEcCtD
Lamivudine—Myalgia—Epirubicin—hematologic cancer	4.24e-06	6.67e-05	CcSEcCtD
Lamivudine—Anxiety—Epirubicin—hematologic cancer	4.22e-06	6.65e-05	CcSEcCtD
Lamivudine—Pruritus—Dexamethasone—hematologic cancer	4.22e-06	6.64e-05	CcSEcCtD
Lamivudine—Pruritus—Betamethasone—hematologic cancer	4.22e-06	6.64e-05	CcSEcCtD
Lamivudine—Skin disorder—Methotrexate—hematologic cancer	4.22e-06	6.64e-05	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.21e-06	6.62e-05	CcSEcCtD
Lamivudine—Hyperhidrosis—Methotrexate—hematologic cancer	4.2e-06	6.6e-05	CcSEcCtD
Lamivudine—Discomfort—Epirubicin—hematologic cancer	4.19e-06	6.59e-05	CcSEcCtD
Lamivudine—Vomiting—Triamcinolone—hematologic cancer	4.18e-06	6.58e-05	CcSEcCtD
Lamivudine—Malaise—Doxorubicin—hematologic cancer	4.15e-06	6.54e-05	CcSEcCtD
Lamivudine—Rash—Triamcinolone—hematologic cancer	4.14e-06	6.52e-05	CcSEcCtD
Lamivudine—Dry mouth—Epirubicin—hematologic cancer	4.14e-06	6.52e-05	CcSEcCtD
Lamivudine—Dermatitis—Triamcinolone—hematologic cancer	4.14e-06	6.52e-05	CcSEcCtD
Lamivudine—Vertigo—Doxorubicin—hematologic cancer	4.14e-06	6.51e-05	CcSEcCtD
Lamivudine—Anorexia—Methotrexate—hematologic cancer	4.14e-06	6.51e-05	CcSEcCtD
Lamivudine—Syncope—Doxorubicin—hematologic cancer	4.13e-06	6.5e-05	CcSEcCtD
Lamivudine—Urticaria—Prednisone—hematologic cancer	4.13e-06	6.49e-05	CcSEcCtD
Lamivudine—Leukopenia—Doxorubicin—hematologic cancer	4.12e-06	6.49e-05	CcSEcCtD
Lamivudine—Headache—Triamcinolone—hematologic cancer	4.12e-06	6.48e-05	CcSEcCtD
Lamivudine—Abdominal pain—Prednisone—hematologic cancer	4.11e-06	6.46e-05	CcSEcCtD
Lamivudine—Body temperature increased—Prednisone—hematologic cancer	4.11e-06	6.46e-05	CcSEcCtD
Lamivudine—Confusional state—Epirubicin—hematologic cancer	4.1e-06	6.45e-05	CcSEcCtD
Lamivudine—Diarrhoea—Dexamethasone—hematologic cancer	4.08e-06	6.42e-05	CcSEcCtD
Lamivudine—Diarrhoea—Betamethasone—hematologic cancer	4.08e-06	6.42e-05	CcSEcCtD
Lamivudine—Anaphylactic shock—Epirubicin—hematologic cancer	4.06e-06	6.39e-05	CcSEcCtD
Lamivudine—Oedema—Epirubicin—hematologic cancer	4.06e-06	6.39e-05	CcSEcCtD
Lamivudine—Hypotension—Methotrexate—hematologic cancer	4.06e-06	6.38e-05	CcSEcCtD
Lamivudine—Loss of consciousness—Doxorubicin—hematologic cancer	4.05e-06	6.37e-05	CcSEcCtD
Lamivudine—Infection—Epirubicin—hematologic cancer	4.04e-06	6.35e-05	CcSEcCtD
Lamivudine—Cough—Doxorubicin—hematologic cancer	4.02e-06	6.32e-05	CcSEcCtD
Lamivudine—Shock—Epirubicin—hematologic cancer	4e-06	6.29e-05	CcSEcCtD
Lamivudine—Convulsion—Doxorubicin—hematologic cancer	3.99e-06	6.28e-05	CcSEcCtD
Lamivudine—Nervous system disorder—Epirubicin—hematologic cancer	3.98e-06	6.27e-05	CcSEcCtD
Lamivudine—Thrombocytopenia—Epirubicin—hematologic cancer	3.98e-06	6.26e-05	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.95e-06	6.22e-05	CcSEcCtD
Lamivudine—Skin disorder—Epirubicin—hematologic cancer	3.95e-06	6.21e-05	CcSEcCtD
Lamivudine—Dizziness—Betamethasone—hematologic cancer	3.94e-06	6.21e-05	CcSEcCtD
Lamivudine—Dizziness—Dexamethasone—hematologic cancer	3.94e-06	6.21e-05	CcSEcCtD
Lamivudine—Hyperhidrosis—Epirubicin—hematologic cancer	3.93e-06	6.18e-05	CcSEcCtD
Lamivudine—Insomnia—Methotrexate—hematologic cancer	3.93e-06	6.18e-05	CcSEcCtD
Lamivudine—Chest pain—Doxorubicin—hematologic cancer	3.92e-06	6.17e-05	CcSEcCtD
Lamivudine—Myalgia—Doxorubicin—hematologic cancer	3.92e-06	6.17e-05	CcSEcCtD
Lamivudine—Arthralgia—Doxorubicin—hematologic cancer	3.92e-06	6.17e-05	CcSEcCtD
Lamivudine—Anxiety—Doxorubicin—hematologic cancer	3.91e-06	6.15e-05	CcSEcCtD
Lamivudine—Nausea—Triamcinolone—hematologic cancer	3.9e-06	6.14e-05	CcSEcCtD
Lamivudine—Paraesthesia—Methotrexate—hematologic cancer	3.9e-06	6.13e-05	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.89e-06	6.13e-05	CcSEcCtD
Lamivudine—Discomfort—Doxorubicin—hematologic cancer	3.87e-06	6.1e-05	CcSEcCtD
Lamivudine—Anorexia—Epirubicin—hematologic cancer	3.87e-06	6.09e-05	CcSEcCtD
Lamivudine—Dyspnoea—Methotrexate—hematologic cancer	3.87e-06	6.09e-05	CcSEcCtD
Lamivudine—Somnolence—Methotrexate—hematologic cancer	3.86e-06	6.07e-05	CcSEcCtD
Lamivudine—Dry mouth—Doxorubicin—hematologic cancer	3.83e-06	6.03e-05	CcSEcCtD
Lamivudine—Hypersensitivity—Prednisone—hematologic cancer	3.83e-06	6.02e-05	CcSEcCtD
Lamivudine—Dyspepsia—Methotrexate—hematologic cancer	3.82e-06	6.01e-05	CcSEcCtD
Lamivudine—Hypotension—Epirubicin—hematologic cancer	3.8e-06	5.97e-05	CcSEcCtD
Lamivudine—Vomiting—Betamethasone—hematologic cancer	3.79e-06	5.97e-05	CcSEcCtD
Lamivudine—Vomiting—Dexamethasone—hematologic cancer	3.79e-06	5.97e-05	CcSEcCtD
Lamivudine—Confusional state—Doxorubicin—hematologic cancer	3.79e-06	5.96e-05	CcSEcCtD
Lamivudine—Decreased appetite—Methotrexate—hematologic cancer	3.77e-06	5.94e-05	CcSEcCtD
Lamivudine—Rash—Betamethasone—hematologic cancer	3.76e-06	5.92e-05	CcSEcCtD
Lamivudine—Rash—Dexamethasone—hematologic cancer	3.76e-06	5.92e-05	CcSEcCtD
Lamivudine—Oedema—Doxorubicin—hematologic cancer	3.76e-06	5.92e-05	CcSEcCtD
Lamivudine—Anaphylactic shock—Doxorubicin—hematologic cancer	3.76e-06	5.92e-05	CcSEcCtD
Lamivudine—Dermatitis—Betamethasone—hematologic cancer	3.76e-06	5.91e-05	CcSEcCtD
Lamivudine—Dermatitis—Dexamethasone—hematologic cancer	3.76e-06	5.91e-05	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.75e-06	5.9e-05	CcSEcCtD
Lamivudine—Fatigue—Methotrexate—hematologic cancer	3.74e-06	5.89e-05	CcSEcCtD
Lamivudine—Headache—Dexamethasone—hematologic cancer	3.74e-06	5.88e-05	CcSEcCtD
Lamivudine—Headache—Betamethasone—hematologic cancer	3.74e-06	5.88e-05	CcSEcCtD
Lamivudine—Infection—Doxorubicin—hematologic cancer	3.73e-06	5.88e-05	CcSEcCtD
Lamivudine—Asthenia—Prednisone—hematologic cancer	3.73e-06	5.86e-05	CcSEcCtD
Lamivudine—Pain—Methotrexate—hematologic cancer	3.71e-06	5.84e-05	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.7e-06	5.82e-05	CcSEcCtD
Lamivudine—Shock—Doxorubicin—hematologic cancer	3.7e-06	5.82e-05	CcSEcCtD
Lamivudine—Nervous system disorder—Doxorubicin—hematologic cancer	3.69e-06	5.8e-05	CcSEcCtD
Lamivudine—Thrombocytopenia—Doxorubicin—hematologic cancer	3.68e-06	5.79e-05	CcSEcCtD
Lamivudine—Pruritus—Prednisone—hematologic cancer	3.67e-06	5.78e-05	CcSEcCtD
Lamivudine—Insomnia—Epirubicin—hematologic cancer	3.67e-06	5.78e-05	CcSEcCtD
Lamivudine—Skin disorder—Doxorubicin—hematologic cancer	3.65e-06	5.75e-05	CcSEcCtD
Lamivudine—Paraesthesia—Epirubicin—hematologic cancer	3.65e-06	5.74e-05	CcSEcCtD
Lamivudine—Hyperhidrosis—Doxorubicin—hematologic cancer	3.63e-06	5.72e-05	CcSEcCtD
Lamivudine—Dyspnoea—Epirubicin—hematologic cancer	3.62e-06	5.7e-05	CcSEcCtD
Lamivudine—Somnolence—Epirubicin—hematologic cancer	3.61e-06	5.68e-05	CcSEcCtD
Lamivudine—Anorexia—Doxorubicin—hematologic cancer	3.58e-06	5.64e-05	CcSEcCtD
Lamivudine—Feeling abnormal—Methotrexate—hematologic cancer	3.58e-06	5.63e-05	CcSEcCtD
Lamivudine—Dyspepsia—Epirubicin—hematologic cancer	3.58e-06	5.63e-05	CcSEcCtD
Lamivudine—Diarrhoea—Prednisone—hematologic cancer	3.55e-06	5.59e-05	CcSEcCtD
Lamivudine—Gastrointestinal pain—Methotrexate—hematologic cancer	3.55e-06	5.59e-05	CcSEcCtD
Lamivudine—Nausea—Dexamethasone—hematologic cancer	3.54e-06	5.57e-05	CcSEcCtD
Lamivudine—Nausea—Betamethasone—hematologic cancer	3.54e-06	5.57e-05	CcSEcCtD
Lamivudine—Decreased appetite—Epirubicin—hematologic cancer	3.53e-06	5.56e-05	CcSEcCtD
Lamivudine—Hypotension—Doxorubicin—hematologic cancer	3.51e-06	5.53e-05	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.51e-06	5.52e-05	CcSEcCtD
Lamivudine—Fatigue—Epirubicin—hematologic cancer	3.5e-06	5.51e-05	CcSEcCtD
Lamivudine—Pain—Epirubicin—hematologic cancer	3.47e-06	5.47e-05	CcSEcCtD
Lamivudine—Constipation—Epirubicin—hematologic cancer	3.47e-06	5.47e-05	CcSEcCtD
Lamivudine—Urticaria—Methotrexate—hematologic cancer	3.45e-06	5.43e-05	CcSEcCtD
Lamivudine—Dizziness—Prednisone—hematologic cancer	3.43e-06	5.41e-05	CcSEcCtD
Lamivudine—Abdominal pain—Methotrexate—hematologic cancer	3.43e-06	5.4e-05	CcSEcCtD
Lamivudine—Body temperature increased—Methotrexate—hematologic cancer	3.43e-06	5.4e-05	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.42e-06	5.39e-05	CcSEcCtD
Lamivudine—Insomnia—Doxorubicin—hematologic cancer	3.4e-06	5.35e-05	CcSEcCtD
Lamivudine—Paraesthesia—Doxorubicin—hematologic cancer	3.37e-06	5.31e-05	CcSEcCtD
Lamivudine—Dyspnoea—Doxorubicin—hematologic cancer	3.35e-06	5.27e-05	CcSEcCtD
Lamivudine—Feeling abnormal—Epirubicin—hematologic cancer	3.35e-06	5.27e-05	CcSEcCtD
Lamivudine—Somnolence—Doxorubicin—hematologic cancer	3.34e-06	5.26e-05	CcSEcCtD
Lamivudine—Gastrointestinal pain—Epirubicin—hematologic cancer	3.32e-06	5.23e-05	CcSEcCtD
Lamivudine—Dyspepsia—Doxorubicin—hematologic cancer	3.31e-06	5.21e-05	CcSEcCtD
Lamivudine—Vomiting—Prednisone—hematologic cancer	3.3e-06	5.2e-05	CcSEcCtD
Lamivudine—Rash—Prednisone—hematologic cancer	3.27e-06	5.15e-05	CcSEcCtD
Lamivudine—Dermatitis—Prednisone—hematologic cancer	3.27e-06	5.15e-05	CcSEcCtD
Lamivudine—Decreased appetite—Doxorubicin—hematologic cancer	3.27e-06	5.14e-05	CcSEcCtD
Lamivudine—Headache—Prednisone—hematologic cancer	3.25e-06	5.12e-05	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.24e-06	5.11e-05	CcSEcCtD
Lamivudine—Fatigue—Doxorubicin—hematologic cancer	3.24e-06	5.1e-05	CcSEcCtD
Lamivudine—Urticaria—Epirubicin—hematologic cancer	3.23e-06	5.08e-05	CcSEcCtD
Lamivudine—Pain—Doxorubicin—hematologic cancer	3.21e-06	5.06e-05	CcSEcCtD
Lamivudine—Constipation—Doxorubicin—hematologic cancer	3.21e-06	5.06e-05	CcSEcCtD
Lamivudine—Abdominal pain—Epirubicin—hematologic cancer	3.21e-06	5.05e-05	CcSEcCtD
Lamivudine—Body temperature increased—Epirubicin—hematologic cancer	3.21e-06	5.05e-05	CcSEcCtD
Lamivudine—Hypersensitivity—Methotrexate—hematologic cancer	3.2e-06	5.03e-05	CcSEcCtD
Lamivudine—Asthenia—Methotrexate—hematologic cancer	3.11e-06	4.9e-05	CcSEcCtD
Lamivudine—Feeling abnormal—Doxorubicin—hematologic cancer	3.1e-06	4.87e-05	CcSEcCtD
Lamivudine—Nausea—Prednisone—hematologic cancer	3.08e-06	4.86e-05	CcSEcCtD
Lamivudine—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.07e-06	4.84e-05	CcSEcCtD
Lamivudine—Pruritus—Methotrexate—hematologic cancer	3.07e-06	4.83e-05	CcSEcCtD
Lamivudine—Hypersensitivity—Epirubicin—hematologic cancer	2.99e-06	4.71e-05	CcSEcCtD
Lamivudine—Urticaria—Doxorubicin—hematologic cancer	2.99e-06	4.7e-05	CcSEcCtD
Lamivudine—Abdominal pain—Doxorubicin—hematologic cancer	2.97e-06	4.68e-05	CcSEcCtD
Lamivudine—Body temperature increased—Doxorubicin—hematologic cancer	2.97e-06	4.68e-05	CcSEcCtD
Lamivudine—Diarrhoea—Methotrexate—hematologic cancer	2.97e-06	4.67e-05	CcSEcCtD
Lamivudine—Asthenia—Epirubicin—hematologic cancer	2.91e-06	4.59e-05	CcSEcCtD
Lamivudine—Pruritus—Epirubicin—hematologic cancer	2.87e-06	4.52e-05	CcSEcCtD
Lamivudine—Dizziness—Methotrexate—hematologic cancer	2.87e-06	4.52e-05	CcSEcCtD
Lamivudine—Diarrhoea—Epirubicin—hematologic cancer	2.78e-06	4.37e-05	CcSEcCtD
Lamivudine—Hypersensitivity—Doxorubicin—hematologic cancer	2.77e-06	4.36e-05	CcSEcCtD
Lamivudine—Vomiting—Methotrexate—hematologic cancer	2.76e-06	4.34e-05	CcSEcCtD
Lamivudine—Rash—Methotrexate—hematologic cancer	2.74e-06	4.31e-05	CcSEcCtD
Lamivudine—Dermatitis—Methotrexate—hematologic cancer	2.73e-06	4.3e-05	CcSEcCtD
Lamivudine—Headache—Methotrexate—hematologic cancer	2.72e-06	4.28e-05	CcSEcCtD
Lamivudine—Asthenia—Doxorubicin—hematologic cancer	2.7e-06	4.24e-05	CcSEcCtD
Lamivudine—Dizziness—Epirubicin—hematologic cancer	2.69e-06	4.23e-05	CcSEcCtD
Lamivudine—Pruritus—Doxorubicin—hematologic cancer	2.66e-06	4.18e-05	CcSEcCtD
Lamivudine—Vomiting—Epirubicin—hematologic cancer	2.58e-06	4.06e-05	CcSEcCtD
Lamivudine—Nausea—Methotrexate—hematologic cancer	2.58e-06	4.06e-05	CcSEcCtD
Lamivudine—Diarrhoea—Doxorubicin—hematologic cancer	2.57e-06	4.05e-05	CcSEcCtD
Lamivudine—Rash—Epirubicin—hematologic cancer	2.56e-06	4.03e-05	CcSEcCtD
Lamivudine—Dermatitis—Epirubicin—hematologic cancer	2.56e-06	4.03e-05	CcSEcCtD
Lamivudine—Headache—Epirubicin—hematologic cancer	2.54e-06	4e-05	CcSEcCtD
Lamivudine—Dizziness—Doxorubicin—hematologic cancer	2.49e-06	3.91e-05	CcSEcCtD
Lamivudine—Nausea—Epirubicin—hematologic cancer	2.41e-06	3.8e-05	CcSEcCtD
Lamivudine—Vomiting—Doxorubicin—hematologic cancer	2.39e-06	3.76e-05	CcSEcCtD
Lamivudine—Rash—Doxorubicin—hematologic cancer	2.37e-06	3.73e-05	CcSEcCtD
Lamivudine—Dermatitis—Doxorubicin—hematologic cancer	2.37e-06	3.73e-05	CcSEcCtD
Lamivudine—Headache—Doxorubicin—hematologic cancer	2.35e-06	3.71e-05	CcSEcCtD
Lamivudine—Nausea—Doxorubicin—hematologic cancer	2.23e-06	3.51e-05	CcSEcCtD
Lamivudine—ABCC1—Disease—PDGFA—hematologic cancer	1.31e-06	3.6e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ABCB1—hematologic cancer	1.31e-06	3.59e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—VEGFA—hematologic cancer	1.3e-06	3.59e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ENO2—hematologic cancer	1.3e-06	3.59e-05	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—AKT1—hematologic cancer	1.3e-06	3.58e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CD44—hematologic cancer	1.3e-06	3.57e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—NQO1—hematologic cancer	1.3e-06	3.57e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.29e-06	3.56e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.29e-06	3.55e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KITLG—hematologic cancer	1.29e-06	3.55e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—NRAS—hematologic cancer	1.29e-06	3.55e-05	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.28e-06	3.54e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.27e-06	3.5e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.27e-06	3.49e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—NCOR1—hematologic cancer	1.27e-06	3.49e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GSTM1—hematologic cancer	1.27e-06	3.49e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTT1—hematologic cancer	1.27e-06	3.48e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—STAT5A—hematologic cancer	1.26e-06	3.47e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.25e-06	3.45e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN2B—hematologic cancer	1.25e-06	3.44e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.25e-06	3.44e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.25e-06	3.43e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CB—hematologic cancer	1.24e-06	3.42e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SDC1—hematologic cancer	1.24e-06	3.4e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—MAPK3—hematologic cancer	1.23e-06	3.4e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYCS—hematologic cancer	1.23e-06	3.37e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.22e-06	3.36e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—MTHFR—hematologic cancer	1.22e-06	3.35e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—HSP90AA1—hematologic cancer	1.22e-06	3.35e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—FHL2—hematologic cancer	1.21e-06	3.33e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD86—hematologic cancer	1.21e-06	3.33e-05	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.2e-06	3.31e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TGFB1—hematologic cancer	1.2e-06	3.3e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HES1—hematologic cancer	1.19e-06	3.28e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.19e-06	3.28e-05	CbGpPWpGaD
Lamivudine—NME2—Metabolism—AKT1—hematologic cancer	1.19e-06	3.28e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.19e-06	3.28e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AGRN—hematologic cancer	1.19e-06	3.27e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NCOR1—hematologic cancer	1.19e-06	3.26e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.18e-06	3.26e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FGF1—hematologic cancer	1.17e-06	3.23e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.16e-06	3.19e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FOXO1—hematologic cancer	1.16e-06	3.18e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PDGFRB—hematologic cancer	1.15e-06	3.18e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CD44—hematologic cancer	1.14e-06	3.14e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NQO1—hematologic cancer	1.14e-06	3.14e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PDGFRA—hematologic cancer	1.14e-06	3.13e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—JAK1—hematologic cancer	1.13e-06	3.12e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PRKCG—hematologic cancer	1.13e-06	3.12e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NQO1—hematologic cancer	1.13e-06	3.11e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CD44—hematologic cancer	1.13e-06	3.11e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.13e-06	3.11e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—IDH2—hematologic cancer	1.12e-06	3.1e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HMMR—hematologic cancer	1.12e-06	3.1e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—MTHFR—hematologic cancer	1.12e-06	3.08e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—KRAS—hematologic cancer	1.11e-06	3.05e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.11e-06	3.05e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PIK3CA—hematologic cancer	1.1e-06	3.04e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—HRAS—hematologic cancer	1.1e-06	3.03e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.1e-06	3.02e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTP1—hematologic cancer	1.08e-06	2.97e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYCS—hematologic cancer	1.08e-06	2.97e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTEN—hematologic cancer	1.07e-06	2.96e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—HSP90AA1—hematologic cancer	1.07e-06	2.95e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYCS—hematologic cancer	1.07e-06	2.94e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.07e-06	2.94e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—HSP90AA1—hematologic cancer	1.06e-06	2.92e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ARNTL—hematologic cancer	1.06e-06	2.91e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CD44—hematologic cancer	1.05e-06	2.89e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NQO1—hematologic cancer	1.05e-06	2.89e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MTHFR—hematologic cancer	1.05e-06	2.88e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.05e-06	2.88e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HLA-A—hematologic cancer	1.04e-06	2.88e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TERT—hematologic cancer	1.04e-06	2.88e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.04e-06	2.86e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.04e-06	2.85e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ACP5—hematologic cancer	1.03e-06	2.83e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CA9—hematologic cancer	1.03e-06	2.83e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—HRAS—hematologic cancer	1.03e-06	2.83e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CG—hematologic cancer	1.02e-06	2.82e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—EP300—hematologic cancer	1.02e-06	2.82e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ABCB1—hematologic cancer	1.02e-06	2.82e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PDGFB—hematologic cancer	1.02e-06	2.81e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CA—hematologic cancer	1.02e-06	2.81e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NCOR2—hematologic cancer	1.02e-06	2.8e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TSC2—hematologic cancer	9.97e-07	2.74e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYCS—hematologic cancer	9.95e-07	2.74e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTM1—hematologic cancer	9.93e-07	2.73e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—NCOR1—hematologic cancer	9.93e-07	2.73e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—HSP90AA1—hematologic cancer	9.89e-07	2.72e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.87e-07	2.72e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—hematologic cancer	9.86e-07	2.71e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—IDH1—hematologic cancer	9.67e-07	2.66e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	9.67e-07	2.66e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	9.59e-07	2.64e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FGFR3—hematologic cancer	9.59e-07	2.64e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TXN—hematologic cancer	9.56e-07	2.63e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTO1—hematologic cancer	9.56e-07	2.63e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ABCC3—hematologic cancer	9.56e-07	2.63e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTP1—hematologic cancer	9.51e-07	2.62e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CREBBP—hematologic cancer	9.49e-07	2.61e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—HRAS—hematologic cancer	9.43e-07	2.6e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTP1—hematologic cancer	9.41e-07	2.59e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CG—hematologic cancer	9.41e-07	2.59e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SPHK1—hematologic cancer	9.36e-07	2.58e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—BAD—hematologic cancer	9.09e-07	2.5e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AKT1—hematologic cancer	9.02e-07	2.48e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOTCH1—hematologic cancer	9e-07	2.48e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ABCB1—hematologic cancer	9e-07	2.48e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CD—hematologic cancer	9e-07	2.48e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—UGT1A1—hematologic cancer	8.99e-07	2.48e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ABCB1—hematologic cancer	8.91e-07	2.45e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ALB—hematologic cancer	8.88e-07	2.45e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD80—hematologic cancer	8.82e-07	2.43e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	8.81e-07	2.43e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KIT—hematologic cancer	8.8e-07	2.42e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—MTHFR—hematologic cancer	8.77e-07	2.42e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTP1—hematologic cancer	8.77e-07	2.41e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CRABP1—hematologic cancer	8.75e-07	2.41e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC22A1—hematologic cancer	8.75e-07	2.41e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NCOR1—hematologic cancer	8.74e-07	2.41e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTM1—hematologic cancer	8.74e-07	2.41e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CREBBP—hematologic cancer	8.72e-07	2.4e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTPN11—hematologic cancer	8.65e-07	2.38e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTM1—hematologic cancer	8.65e-07	2.38e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NCOR1—hematologic cancer	8.65e-07	2.38e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALOX5—hematologic cancer	8.52e-07	2.35e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	8.52e-07	2.35e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3R1—hematologic cancer	8.5e-07	2.34e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CREB1—hematologic cancer	8.38e-07	2.31e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—AKT1—hematologic cancer	8.33e-07	2.29e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ABCB1—hematologic cancer	8.3e-07	2.29e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—BRAF—hematologic cancer	8.27e-07	2.28e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CD—hematologic cancer	8.27e-07	2.28e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NUP98—hematologic cancer	8.26e-07	2.27e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6R—hematologic cancer	8.17e-07	2.25e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ALB—hematologic cancer	8.17e-07	2.25e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CREBBP—hematologic cancer	8.16e-07	2.25e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTM1—hematologic cancer	8.06e-07	2.22e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NCOR1—hematologic cancer	8.06e-07	2.22e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ADCY7—hematologic cancer	8.01e-07	2.21e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NCOA3—hematologic cancer	8.01e-07	2.21e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NUP214—hematologic cancer	7.96e-07	2.19e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CB—hematologic cancer	7.84e-07	2.16e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3R1—hematologic cancer	7.81e-07	2.15e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ABCG2—hematologic cancer	7.8e-07	2.15e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MTR—hematologic cancer	7.8e-07	2.15e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAP2K1—hematologic cancer	7.79e-07	2.14e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CD—hematologic cancer	7.74e-07	2.13e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.73e-07	2.13e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—MTHFR—hematologic cancer	7.72e-07	2.13e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ENO2—hematologic cancer	7.65e-07	2.11e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—MTHFR—hematologic cancer	7.64e-07	2.1e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CA—hematologic cancer	7.57e-07	2.08e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTT1—hematologic cancer	7.42e-07	2.04e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FGF2—hematologic cancer	7.41e-07	2.04e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CG—hematologic cancer	7.37e-07	2.03e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3R1—hematologic cancer	7.31e-07	2.01e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SDC1—hematologic cancer	7.25e-07	2e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CB—hematologic cancer	7.21e-07	1.98e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	7.2e-07	1.98e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—MTHFR—hematologic cancer	7.12e-07	1.96e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—JAK2—hematologic cancer	7.1e-07	1.96e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.94e-07	1.91e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MDM2—hematologic cancer	6.93e-07	1.91e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CREBBP—hematologic cancer	6.84e-07	1.88e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTEN—hematologic cancer	6.78e-07	1.87e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MTOR—hematologic cancer	6.75e-07	1.86e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CB—hematologic cancer	6.75e-07	1.86e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD4—hematologic cancer	6.73e-07	1.85e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	6.5e-07	1.79e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CG—hematologic cancer	6.49e-07	1.79e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CD—hematologic cancer	6.48e-07	1.78e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—EP300—hematologic cancer	6.46e-07	1.78e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CG—hematologic cancer	6.42e-07	1.77e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ALB—hematologic cancer	6.4e-07	1.76e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1B—hematologic cancer	6.33e-07	1.74e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTEN—hematologic cancer	6.23e-07	1.72e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKT1—hematologic cancer	6.19e-07	1.7e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CD44—hematologic cancer	6.16e-07	1.7e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NQO1—hematologic cancer	6.16e-07	1.7e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3R1—hematologic cancer	6.12e-07	1.68e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CREBBP—hematologic cancer	6.01e-07	1.66e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CG—hematologic cancer	5.98e-07	1.65e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CREBBP—hematologic cancer	5.95e-07	1.64e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—EP300—hematologic cancer	5.94e-07	1.64e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1A—hematologic cancer	5.84e-07	1.61e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYCS—hematologic cancer	5.83e-07	1.61e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTEN—hematologic cancer	5.83e-07	1.6e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	5.79e-07	1.6e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CD—hematologic cancer	5.7e-07	1.57e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CB—hematologic cancer	5.65e-07	1.56e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CD—hematologic cancer	5.64e-07	1.55e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALB—hematologic cancer	5.63e-07	1.55e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALB—hematologic cancer	5.57e-07	1.53e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EP300—hematologic cancer	5.56e-07	1.53e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CREBBP—hematologic cancer	5.55e-07	1.53e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SRC—hematologic cancer	5.41e-07	1.49e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3R1—hematologic cancer	5.39e-07	1.48e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3R1—hematologic cancer	5.33e-07	1.47e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CD—hematologic cancer	5.26e-07	1.45e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—STAT3—hematologic cancer	5.21e-07	1.44e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NRAS—hematologic cancer	5.2e-07	1.43e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALB—hematologic cancer	5.19e-07	1.43e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTP1—hematologic cancer	5.14e-07	1.42e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAPK3—hematologic cancer	4.98e-07	1.37e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CB—hematologic cancer	4.97e-07	1.37e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3R1—hematologic cancer	4.97e-07	1.37e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CB—hematologic cancer	4.92e-07	1.35e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTEN—hematologic cancer	4.88e-07	1.34e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MYC—hematologic cancer	4.84e-07	1.33e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TGFB1—hematologic cancer	4.83e-07	1.33e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CA—hematologic cancer	4.78e-07	1.32e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NCOR1—hematologic cancer	4.72e-07	1.3e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTM1—hematologic cancer	4.72e-07	1.3e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—EP300—hematologic cancer	4.66e-07	1.28e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CB—hematologic cancer	4.59e-07	1.26e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KRAS—hematologic cancer	4.48e-07	1.23e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CA—hematologic cancer	4.4e-07	1.21e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTEN—hematologic cancer	4.3e-07	1.18e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTEN—hematologic cancer	4.25e-07	1.17e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MTHFR—hematologic cancer	4.17e-07	1.15e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CA—hematologic cancer	4.11e-07	1.13e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—EP300—hematologic cancer	4.1e-07	1.13e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—EP300—hematologic cancer	4.05e-07	1.12e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTEN—hematologic cancer	3.96e-07	1.09e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKT1—hematologic cancer	3.91e-07	1.08e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HRAS—hematologic cancer	3.8e-07	1.05e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—EP300—hematologic cancer	3.78e-07	1.04e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6—hematologic cancer	3.64e-07	1e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKT1—hematologic cancer	3.59e-07	9.88e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CG—hematologic cancer	3.51e-07	9.66e-06	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CA—hematologic cancer	3.44e-07	9.48e-06	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT1—hematologic cancer	3.36e-07	9.25e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CREBBP—hematologic cancer	3.25e-07	8.95e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CD—hematologic cancer	3.08e-07	8.49e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALB—hematologic cancer	3.04e-07	8.38e-06	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CA—hematologic cancer	3.03e-07	8.34e-06	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CA—hematologic cancer	3e-07	8.26e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.91e-07	8.02e-06	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKT1—hematologic cancer	2.81e-07	7.75e-06	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CA—hematologic cancer	2.8e-07	7.7e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.69e-07	7.4e-06	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKT1—hematologic cancer	2.48e-07	6.82e-06	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKT1—hematologic cancer	2.45e-07	6.75e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTEN—hematologic cancer	2.32e-07	6.39e-06	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKT1—hematologic cancer	2.28e-07	6.29e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—EP300—hematologic cancer	2.21e-07	6.1e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.64e-07	4.51e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKT1—hematologic cancer	1.34e-07	3.68e-06	CbGpPWpGaD
